RIGEL PHARMACEUTICALS, INC. (RIGL) Operating cash flow 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$75.7MFY2025 · since FY2016: -$75.9M → $75.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.7M | +140.4% |
| FY2024 | $31.5M | +648.0% |
| FY2023 | -$5.7M | +92.2% |
| FY2022 | -$73.8M | -1354.8% |
| FY2021 | $5.9M | +111.3% |
| FY2020 | -$52.2M | -25.7% |
| FY2019 | -$41.5M | +29.4% |
| FY2018 | -$58.8M | +24.2% |
| FY2017 | -$77.6M | -2.2% |
| FY2016 | -$75.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Net marginRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →